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a b s t r a c t
RNA interference (RNAi) is the major defense of many arthropods against arthropod-borne RNA viruses
(arboviruses), but the role of RNAi in vertebrate immunity to arboviruses is not clear. RNA viruses can
trigger RNAi in vertebrate cells, but the vertebrate interferon response may obscure this interaction. We
quantiﬁed virus-derived small RNAs (vRNAs) generated by mosquito (U4.4) cells and interferon-deﬁcient
(Vero) and interferon-competent (HuH-7) mammalian cells infected with a single isolate of mosquito-
borne dengue virus. Mosquito cells produced signiﬁcantly more vRNAs than mammalian cells, and
mosquito cell vRNAs were derived from both the positive- and negative-sense dengue genomes whereas
mammalian cell vRNAs were derived primarily from positive-sense genome. Mosquito cell vRNAs were
predominantly 21 nucleotides in length whereas mammalian cell vRNAs were between 12 and 36
nucleotides with a modest peak at 24 nucleotides. Hot-spots, regions of the virus genome that generated
a disproportionate number of vRNAs, overlapped among the cell lines.
& 2014 Elsevier Inc. All rights reserved.
Introduction
RNA interference (RNAi) is an ancient and ubiquitous defense of
eukaryotes against RNA viruses (Ding and Voinnet, 2007; Zhou and
Rana, 2013). During the RNAi response, Dicer recognizes double-
stranded RNA (dsRNA) from the virus genome and cleaves it into
21–23 nucleotide (nt) antiviral small interfering RNAs (viRNAs). The
viRNA is loaded onto the RNA Induced Silencing Complex (RISC),
which unwinds the two strands, selects one as a guide strand, and
then binds single-stranded RNA complementary to the guide strand
and cleaves it. For positive-sense RNA viruses, the dsRNA that triggers
RNAi can originate from the pairing of the positive- and negative-
sense genomes in the double-stranded replication intermediate or
from regions of secondary structure in either the positive- or
negative-sense genomes (Sabin et al., 2013).
While the efﬁcacy of RNAi as an innate defense against viral
infection in invertebrate animals has beenwell established, its role as
an antiviral response in vertebrate animals remains controversial
(Svoboda, 2014). In 2013, two studies reported that deletion or
inactivation of the viral suppressor of RNAi (VSR) proteins from
Nodamuravirus (NoV) (Li et al., 2013) and Flock House virus (FHV)
(Maillard et al., 2013) enhanced production of 22 nt viRNAs by
infected mammalian cells in culture and in vivo and enabled RNAi-
mediated suppression of viral replication. Moreover, intact NoV and
encephalomyocarditis virus (EMCV), a mammalian picornavirus,
were shown to stimulate production of viRNAs in pluripotent mouse
embryonic stem cells, which lack an interferon response (Maillard
et al., 2013). These results suggest that previous ambiguity regarding
the antiviral efﬁcacy of RNAi in vertebrates stemmed from the
combined action of virus VSRs and the host interferon response
(Maillard et al., 2013).
The studies discussed above focused on viruses that are main-
tained in direct transmission between either mammals (EMCV) or
insects (FHV and NoV, which only incidentally infect vertebrates). In
the current study, we investigated the virus-derived small RNA
(vRNA) repertoire stimulated by infection of dengue virus (DENV,
genus Flavivirus), an arthropod-borne virus (arbovirus) whose
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life cycle alternates between infection of Aedes mosquitoes and
humans. Dengue virus contains a positive-sense, single-stranded
RNA genome of approximately 11 kilobases. The viral genome
encodes three structural and seven non-structural proteins in a
single open reading frame. The genome is capped at the 50 end with
a type I cap structure but lacks a 30 poly-A tail. The genome is
translated as a single polyprotein that is co- and post-translationally
cleaved by viral and host proteases (Alcaraz-Estrada et al., 2010).
RNAi is known to be the major mosquito defense against infection
by arboviruses, including DENV (Blair, 2011), but the interaction of
arboviruses and RNAi in mammalian cells is not well characterized.
Moreover, there is some evidence that the mammalian interferon
(IFN) response may obscure the RNAi response. Using deep sequen-
cing of small RNAs, Donaszi-Ivanov et al. (2013) found no evidence of
an RNAi response in human embryonic kidney (HEK293) cells
infected with Sindbis virus (SINV), a mosquito-borne alphavirus.
HEK293 cells possess a functional, albeit impaired (Pauli et al., 2008),
IFN response to virus infection. Similarly Parameswaran et al. (2010)
detected only 5 vRNAs in human hepatoma (HuH-7) cells, an IFN-
competent cell line (Zhang et al., 2005), upon infection with DENV
serotype 2 (DENV-2), but they detected 56 vRNAs in the spleen tissue
of an interferon-deﬁcient mouse infected with West Nile virus,
another mosquito-borne ﬂavivirus. These latter data also suggested
an inverse association between the strength of the interferon
response and the likelihood of detecting viRNAs in mammalian cells.
In the current study, we used deep sequencing of small RNAs to
quantify and compare the abundance and genome targeting of vRNAs
produced during DENV-4 infection in mosquito (U4.4) and primate
(Vero and HuH-7) cell lines. The primate cells were chosen to include
one line that is capable of mounting a type-I interferon response (HuH-
7) and one line that is not (Vero), thereby enabling an analysis of the
effect of the interferon response on the vRNA repertoire in cultured cells.
Results and discussion
Abundance of virus-derived small RNAs differs among the three cell
lines
We have found that multiple DENV-3 and DENV-4 strains reach
titers in RNAi-deﬁcient Ae. albopictus C6/36 cells that are one to two logs
higher than those in RNAi-intact A. albopictus U4.4 cells (data for DENV-
3 not shown; see Table 1 for DENV-4). Thus we predicted that rDENV-4
would also replicate to signiﬁcantly higher titers in IFN-deﬁcient Vero
cells than in IFN-intact HuH-7 cells or RNAi-intact U.4.4 cells. Contra this
prediction, rDENV-4 reached a slightly but signiﬁcantly higher titer in
U4.4 cells than HuH-7 or Vero cells, while virus titer in the two
mammalian cell lines did not differ (Table 1). We also predicted, based
on multiple studies demonstrating high viRNA production in infected
insect cells and low viRNA production in infected mammalian cells
(Li et al., 2013; Maillard et al., 2013; Donaszi-Ivanov et al., 2013;
Parameswaran et al., 2010; Leger et al., 2013; Brackney et al., 2009;
Morazzani et al., 2012; Siu et al., 2011; Vodovar et al., 2012), that U4.4
virus-derived small RNAs (vRNAs) would fall into the 21 nt size
category, the canonical size for antiviral small interfering RNAs (viRNAs)
(Blair, 2011), and that such viRNAs would be signiﬁcantly more
abundant in U4.4 cells than mammalian cells. This prediction was
supported, and U4.4 cells produced the greatest number of small RNA
reads in total, the greatest number of 21 nt vRNAs and the highest
percentage of 21 nt vRNAs relative to total small RNAs (Table 1 and
Fig. 1). As shown in Supplementary Fig. 1, the distribution of vRNAs
across size classes was quite similar in each of the three replicates
within a cell type. Finally we predicted, based on the hypothesis of an
inverse association between the IFN response and production of vRNAs,
that Vero cells would produce more vRNAs, and that more of these
would fall in the 21 nt size class, than HuH-7 cells. In fact, we found the
opposite, that HuH-7 cells produced a slightly but not signiﬁcantly
greater absolute number of vRNAs and a signiﬁcantly greater percentage
of vRNAs (Table 1 and Fig. 1). In both mammalian cell lines, 21 nt vRNAs
were a relatively minor component of the vRNA repertoire.
It is notable that the cell line that supported the highest virus titer,
U4.4, was also the only cell line that produced a characteristic viRNA
response. The most likely explanation for this pattern is that the RNAi
pathway is not involved in antiviral immunity in these cultured
mammalian cells. In keeping with the ﬁndings presented here, Bogerd
et al. (2014) have demonstrated that the virus-derived small RNAs
that are produced by HuH-7 cells after DENV infections show a “ﬂat”
distribution across size classes and lack other distinguishing features
of either antiviral siRNAs or virus-derived miRNAs. Bogerd et al. also
showed that human embryonic kidney (HEK) cells and HEK cells in
which the Dicer gene had been ablated (noDice cells) supported
similar levels of replication in a broad panel of different viruses,
including DENV, two other ﬂaviviruses (West Nile and yellow fever
virus), and three other arboviruses (Venezuelan equine encephalitis,
Sindbis and vesicular stomatitis virus). Moreover Seo et al. (2013)
demonstrated that, in cultured HEK293 cells and other cell lines, virus
infection triggered downregulation of the RNAi machinery and
release of the interferon response. Thus, while the role of RNAi in
antiviral defense in vertebrates in vivo remains an open question,
there is a growing evidence that cultured cells do not mount an RNAi-
based defense against virus infection (Cullen et al., 2013). However it
should be kept in mind that both Bogerd et al. (2014) and Seo et al.
(2013) utilized interferon-competent cells in their studies.
While the absolute numbers of vRNAs produced in response to
infection are likely to vary substantially among different studies due
to different experimental conditions, it should be valid to compare the
percentage of vRNAs relative to total small RNAs across studies. In
HuH-7 and Vero cells, vRNAs constituted, on average, 0.25% and 0.17%,
of total small RNAs, similar to the percent of vRNAs produced by HEK
293 cells infected with SINV (0.8%) (Donaszi-Ivanov et al., 2013). Of
the total small RNAs produced by U4.4 cells in the current study,
0.57% were DENV-4-derived vRNAs, a dramatically lower percentage
than was found for Rift Valley fever virus (RVFV; which ranged from
4% to 24% across early and later timepoints) (Leger et al., 2013) or
Semliki Forest virus (SFV; 2.1%) (Siu et al., 2011) in the same cell line.
DENV belongs to a different family (Flaviviridae) than either RVFV
(Bunyaviridae) or SFV (Togaviridae), thus there is no a priori reason to
expect that dynamics of virus replication or viRNA response would be
equivalent among the three viruses. The percentage of DENV-4-
derived vRNAs in cultured U4.4 cells was higher than the percentage
of small RNAs that mapped to the DENV-2 genome in infected Aedes
aegypti (0.005–0.06%) (Hess et al., 2011) or the West Nile virus (WNV)
genome in infected Culex mosquitoes (0.05–0.12%) (Brackney et al.,
2009) but similar to the percentage of vRNAs that mapped to the
chikungunya virus (CHIKV) genome in infected A. aegypti (1%) and
A. albopictus (1.5%) (Morazzani et al., 2012). It must be emphasized
that the milieu for virus replication is much simpler in cultured cells
than in vivo; in the former setting viruses are confronted with only a
single, undifferentiated cell type. Thus, while cultured cells can
represent a tractable system in which to derive early insights into
the mechanisms of mosquito innate immunity, they are not an
adequate model for virus infection of an intact mosquito.
Polarity and size distribution of DENV vRNAs differs in mosquito
and mammalian cells
U4.4 cells infected with rDENV-4 produced predominantly (65.3%)
21 nt vRNAs (Fig. 1), the canonical size for antiviral small interfering
RNAs (viRNAs) (Blair, 2011), and oligonucleotides in this size class from
U4.4 cells are referred to as viRNAs hereafter. Among U4.4 viRNAs
there were approximately equal numbers derived from the positive-
and negative-sense virus genomes (59.3% and 40.7%, respectively),
E.E. Schirtzinger et al. / Virology 476 (2015) 54–60 55
suggesting that this class of viRNAs was derived from double-stranded
RNA replication intermediates. Similar to this study, U4.4 cells infected
with SFV (Siu et al., 2011), A.aegypti infected with DENV-2 (Hess et al.,
2011), and Culex mosquitoes infected with WNV (Brackney et al.,
2009) all produced primarily 21 nt viRNAs that were equally dis-
tributed between the positive- and negative-sense virus genomes.
U4.4 cells infected with RVFV (Leger et al., 2013) or SINV (Vodovar
et al., 2012) and Aedes mosquitoes infected with CHIKV (Morazzani
et al., 2012), in contrast, generated a broader size repertoire of vRNAs,
including small virus-derived RNAs with the characteristics of piwi-
associated RNAs (piRNAs). In these latter studies, vRNAs also showed a
polarity bias depending on the virus genome segment and/or vRNA
size class.
In contrast, vRNAs generated by both mammalian cell lines in this
study were almost exclusively derived from the positive-sense
genome of rDENV-4 (96.2% and 99.0% in HuH-7 and Vero cells,
respectively, Fig. 1), consistent with an approximately 100:1 ratio of
positive to negative strands of the DENV genome produced during
genome replication (Diamond et al., 2002). In both mammalian cell
lines, vRNAs were distributed between 12 and 36 nucleotides, with a
modest peak at 24 nucleotides. With the exception of this peak, these
patterns are similar to those observed for HEK293 cells infected with
SINV (Donaszi-Ivanov et al., 2013). There were only two substantial
differences in the size distribution of vRNAs generated by IFN-
deﬁcient Vero and IFN-competent HuH-7 cells. First, Vero cell vRNAs
showed a relatively large peak in 12–13 nt size class that was absent
in HuH-7 vRNAs. Second, Vero cell viRNAs showed a much more
distinct peak in 24 nt vRNAs than HuH-7 vRNAs, for which the
distribution was much more even (Fig. 1, right-hand panels). There
was no evidence that the vRNAs in the 24 or 25–29 nt size classes
represented piRNAs (Bronkhorst and van Rij, 2014). As shown in
Fig. 2, the only class of vRNAs that showed any clear nt bias was the
24-nt vRNAs derived from Vero cells, which showed a substantial
U bias at the 50 terminus of vRNAs targeting both the positive- and
negative-sense DENV genomes but lacked an A bias at the 10th
position in vRNAs of either polarity. Intriguingly, the vast majority of
Vero-derived, 24-nt vRNAs targeted a single region of the genome, nts
2328–2351, near the 30 end of the E gene. To our knowledge, there is
no evidence of substantial secondary structure at this region, but few
studies to date have attempted to elucidate the structure of the
coding region of the DENV genome outside of the 50 and 30 termini of
the genome. The results of this study contrast with substantial
evidence for production of piRNAs against DENV (Hess et al., 2011),
CHIKV (Morazzani et al., 2012), RVFV (Leger et al., 2013), and SINV
(Vodovar et al., 2012) in mosquito cells in culture and in vivo.
viRNA targeting of the DENV-4 genome
Siu et al. (2011) infected U4.4 cells with SFV and found that
viRNAs clustered into hot-spots and cold-spots, e.g. regions of the
genome that were disproportionately targeted or spared by viRNAs.
When viRNAs from hot and cold spots were synthesized, the cold-
spot viRNAs were signiﬁcantly more effective at suppressing viral
replication. To assess whether the 21 nt vRNAs generated by
mosquito and mammalian cells differed in targeting of the rDENV-
4 genome, we determined the distribution of 21 nt vRNAs across the
genome for each individual replicate as well as all 21 nt vRNAs per
cell line combined for each of the three cell lines (Fig. 3). In all cell
lines, positive-sense vRNAs in this size class were distributed across
the entire genome. Replicates within a cell line showed remarkably
consistent patterns of 21 nt vRNA targeting. Notably, in HuH-7 cells,
but not in Vero or U4.4 cells, negative sense vRNAs were derived only
from the 50 and 30 termini of the genome.
While the paucity of vRNAs in the two mammalian cell lines
makes detection of cold-spots impracticable, it is possible to visually
identify peaks in targeting (hot-spots) in each cell line. In all three
Fig. 1. Size distribution of small RNAs that map to the positive-sense (blue) and negative-sense (red) dengue virus genome in two mammalian (HuH-7 and Vero) and one
mosquito (U4.4) cell lines ﬁve days post-infection with rDENV-4. Each panel represents the combined virus-derived small RNAs from three independent replicates per cell
line. In the left-hand column the Y-axis is scaled to a single standard to represent relative number of virus-derived small RNAs in the three cell lines; in the right-hand
column variable Y-axis scales are used to allow visualization of the distribution of virus-derived small RNAs in each cell line.
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HuH-7 replicates, the 21 nt, positive-sense vRNA repertoire was
dominated by a single major peak, encompassing nts 7872–7892, at
the 50 end of the NS5 gene. The same peak was observed in Vero cell
viRNAs, although additional, sometimes higher, peaks were
observed at nts 2328–2348 at the 30 end of the E gene, nts 9746–
9766 near the 30 end of NS5, and nts 1328–1348, near the 50 end of
the E gene. All of the peaks in 21 nt vRNAs in mammalian cells were
also represented by peaks in 21 nt U4.4 cell viRNAs, though these
were not necessarily the highest peaks in the mosquito cells (Fig. 3).
Thus there is no evidence, at this level of resolution, that 21 nt
vRNAs derived from mammalian and mosquito cells target different
regions of the genome. The highly conserved peaks in RNA targeting
in mammalian cells are intriguing; synthesis and evaluation of the
RNAi functionality of the 21 nt vRNA encompassing nts 7872–7892
of rDENV-4 in mammalian and mosquito cell lines may offer insight
into variation in the regulation and impact of antiviral RNA
interference against arboviruses.
Conclusions
The results of this study reveal that U4.4 mosquito cells infected
with mosquito-borne DENV tended to produce abundant 21 nt
vRNAs derived at approximately equal ratio from the positive- and
negative-sense genomes, suggesting that these were viRNAs pro-
duced from the virus replication intermediate. Mammalian cells
produced signiﬁcantly fewer virus-derived RNAs than mosquito cells,
but IFN-competent HuH-7 cells produced a signiﬁcantly higher
percentage of vRNAs than IFN-deﬁcient Vero cells, opposite to our
initial prediction. Both mammalian cell lines produced vRNAs that
were broadly distributed in size and that were derived primarily
from the positive-sense genome, suggesting that they were not the
product of Dicer processing. vRNAs produced by both mammalian
cell lines showed a modest peak in the 24 nt size class. In contrast to
previous studies of arboviruses, including studies of DENV in vivo
(Hess et al., 2011), there was no evidence that these 24 nt vRNAs
were generated by the Piwi pathway. In all three cell lines, vRNAs
showed hot-spots in their distribution across the genome; hot-spots
produced in mammalian cells were generally also found in mosquito
cells, while mosquito cells yielded additional hot-spots unique to this
cell line. DENV replicated to signiﬁcantly higher titers in the
mosquito cell line relative to the two mammalian cell lines, but this
difference in replication cannot be attributed to either lower produc-
tion of vRNAs in the mosquito cells or differences in vRNA targeting
between the mosquito and mammalian cell lines.
While many previous studies have investigated the vRNA
repertoire produced during arbovirus infection of either vector or
host cells, this is the ﬁrst study to our knowledge inwhich the vRNA
Fig. 2. Density plots and Seqlogos of virus-derived small RNAs of 24 and 25–29 nucleotides in length representing the combined virus-derived small RNAs (N¼3 replicates/
cell line) from HuH-7, Vero and U4.4 cells. A schematic of the dengue virus genome is provided below each panel for orientation. Note variation in the scale of the Y axes
among panels.
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repertoire of a single arbovirus isolate has been characterized in
both vector and host cells concurrently. The use of a common
isolate is important because dengue serotypes, and likely strains,
can vary in their folded structure (Blaney et al., 2008), which may
confound comparisons that utilize different strains in different cell
types. In addition, Lambrechts et al. (2013) have demonstrated a
gene gene interaction between Dicer variants and dengue strains
in A. aegypti; such effects could further confound comparisons in
which different virus strains are tested in different cell types.
Methods
Cell lines
U4.4 cells are an Aedes albopictus cell line that is known to possess
a functional RNAi pathway (Leger et al., 2013; Schnettler et al., 2012)
and to lack, as do all insect cells, the IFN pathway. Vero cells are
African green monkey kidney cells that lack a type-I IFN response
(Desmyter et al., 1968; Emeny andMorgan,1979;Wathelet et al., 1992)
but possess a functional RNAi pathway (Matskevich et al., 2009). HuH-
7 cells are a human hepatoma cell line capable of mounting both
functional RNAi (Kakumani et al., 2013) and IFN (Zhang et al., 2005)
responses. C6/36 cells are an A. albopictus cell line that lack a
functional RNAi response (Brackney et al., 2010); this cell line was
used only as a common substrate for determination of virus titer.
U4.4 cells were cultured in Mitsuhashi and Maramorosch
(HiMedia, VWR, Sugar Land, TX) medium supplemented with 20%
fetal bovine serum (FBS) (Gibco, Life Technologies, Grand Island,
NY), 1.5 mg/ml sodium bicarbonate (Gibco), and 0.05 mg/ml genta-
mycin (Invitrogen, Life Technologies, Grand Island, NY). C6/36 cells
were cultured in Minimum Essential Medium (MEM) supplemented
with 10% FBS, 2 mM L-glutamine (Gibco), 2 mM non-essential
amino acid (Gibco) and 0.05 mg/ml gentamycin (Invitrogen). HuH-
7 cells were cultured in DMEM/F12 medium (Gibco) supplemented
with 10% FBS, 2 mM L-glutamine, and 0.05 mg/ml gentamycin. Vero
cells were cultured in MEM supplemented with 10% FBS, 2 mM
L-glutamine and 0.05 mg/ml gentamycin. U4.4 and C6/36 cells were
maintained at 32 1C, 80% RH in 5% CO2 while HuH-7 and Vero cells
were maintained at 37 1C, 80% RH in 5% CO2.
DENV infection and quantiﬁcation
Triplicate T25 tissue culture-treated ﬂasks of U4.4, HuH-7 and
Vero cells were infected with rDENV-4 (Genbank accession no.
AY648301.1), a recombinant dengue virus derived from DENV-4/
Dominica/814669/1981, at a multiplicity of infection of 1.0. Infected
ﬂasks were incubated for 5 days at conditions appropriate to the
Fig. 3. Density plots of 21 nucleotide, virus-derived small RNAs across the dengue virus genome for each of three replicates as well as all replicates combined in HuH-7, Vero
and U4.4 cells 5 days post-infection with rDENV-4. Reads that map to the positive-sense dengue genome are in blue and reads that map to the negative-sense dengue
genome are in red. A schematic of the dengue virus genome is provided below each column for orientation. Note variation in the scale of the Y axes among panels.
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particular cell line and then the supernatant from each ﬂask was
harvested, combined with 1X SPG (2.18 mM sucrose, 38 mM potas-
sium phosphate [monobasic], 72 mM potassium phosphate [dibasic],
60 mM L-glutamic acid), clariﬁed by centrifugation, and stored in 1 ml
aliquots at 80 1C. Five days was chosen as the infection duration
because in our hands, under the conditions used, DENV generally
reaches peak titer at or just before ﬁve days (Hanley et al., 2008). Viral
titer in supernatants was quantiﬁed in the same cell line used for
culture and also in C6/36 cells by serial dilution and immunostaining
as described previously (Hanley et al., 2008).
Small RNA isolation and sequencing
Small RNAs were isolated from approximately 107 cells in each
of the 9 ﬂasks using the mirVana miRNA Isolation Kit (Ambion, Life
Technologies, Grand Island, NY) according to manufacturer's
instructions for small RNA enrichment. Brieﬂy, cells were lysed
with the kit's lysis solution, phenol:chloroform extracted, and
puriﬁed through a glass ﬁber ﬁlter. Five micrograms of small RNAs
per sample were shipped to the National Center for Genome
Resources (NCGR, Santa Fe, NM) for library preparation and sequen-
cing. Small RNA libraries for each sample were prepared according
to the Illumina TruSeq Small RNA preparation protocol developed
by Illumina Technologies (San Diego, CA). Quality of the total RNA
was tested using Agilent 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA). Then, 50 (GUUCAGAGUUCUACAGUCCGACGAUC) and
30 (TGGAATTCTCGGGTGCCAAGG) adapters, designed to preferen-
tially ligate small RNA, were sequentially ligated to the sample and
samples were reverse transcribed. PCR was performed using
speciﬁc primers that anneal to the ends of the adapter sequences
and introduce a 6-mer barcode. The resulting PCR products were
multiplexed along with other samples with unique 6-mer barcodes
then size selected by polyacrylamide gel electrophoresis at 145–160
base pairs, which captures small RNA molecules up to 36 nucleo-
tides. The resulting pool of libraries was puriﬁed by ethanol
precipitation and validated using Bioanalyzer 2100. Single-end
sequencing was performed on all nine samples using Illumina GA
IIx platform. Each sample was run on a single ﬂow cell (7 lanes) to
obtain 136 base pair reads.
Sequencing analysis
Raw reads were post-processed to remove Illumina adapters/
primers and ΦX DNA contamination. An average of approximately
16.1 million 36 base pairs singleton reads were generated for each
sample (see Table 1 for exact number of reads per sample).
Following this, reads were further processed to detect small RNA
sequencing primers introduced during the small RNA library pre-
paration stage. Cutadapt v1.2.1 (Martin, 2011), a tool speciﬁcally
developed to remove adapters from next generation sequence data
was used for small RNA primer/adapter trimming. Sequence data
resulting from Cutadapt greater than or equal to 14 base pairs were
retained for further mapping and read count generation. The
average read length after trimming was found to be at the expected
length of 21–24 base pairs. Processed reads were then aligned to
the rDENV4 genome using Genomic Short-read Nucleotide Program
(GSNAP version 2011_03_28 (Wu and Nacu, 2011)); because the
sequence data generated for this project were single-end 36 base
pair long reads, the default parameter settings of GSNAP were
deemed appropriate for alignment. By default the INDEL penalty
was set to 1 and a 1 base pair mismatch was allowed in the 14 base
pairs seed region of the sequence reads. Alignments in SAM
(Sequence Alignment/Map) format were converted to BAM (Binary
Alignment/Map) format and further sorted and indexed using
SAMtools v.0.1.19 (Li et al., 2009). The BAM ﬁles were then imported
into the R package, viRome (Watson et al., 2013) to produce graphs
of the distribution of sequence lengths, the position and polarity of
reads along the dengue virus genome and preparation of position
weight matrices for reads of speciﬁc lengths in each cell line for
sequence logo analysis using WebLogo 3 (http://weblogo.berkeley.
edu/logo.cgi) (Crooks et al., 2004; Schneider and Stephens, 1990).
Statistical analysis
Virus titer, total number of small RNA reads and number of vRNAs
were compared among cell lines (N¼3 replicates per line) using a
Tukey–Kramer post-hoc test. Percent of reads aligning to the DENV
genome did not conform to a normal distribution after arcsin-square
root transformation, therefore to compare vRNA percentages among
the three cell lines we initially used a Wilcoxon test, followed, if
signiﬁcant, by pairwise Mann–Whitney U comparisons.
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Table 1
Comparison of small RNAs produced during dengue virus infection of mammalian






















HuH-7 A 19,539,168 a,b 47,648 b 0.24 b 6.02 b 6.20 b
HuH-7 B 15,409,811 a,b 36,520 b 0.24 b 6.16 b 6.19 b
HuH-7 C 14,049,304 a,b 39,668 b 0.28 b 6.24 b 6.38 b
Vero A 13,625,116 b 22,832 b 0.17 c 6.32 a,b 6.17 b
Vero B 11,089,559 b 18,273 b 0.16 c 6.29 a,b 6.04 b
Vero C 10,217,828 b 18,512 b 0.18 c 6.34 a,b 6.04 b
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U4.4 C 19,995,630 a 106,138 a 0.53 a 6.73 a 7.04 a
1 Letters indicate results of a Tukey–Kramer post-hoc test; groups that do not
share a letter are signiﬁcantly different (Po0.05).
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genome (Wilcoxon test, DF¼2, P¼0.027); post-hocMann–Whitney U tests revealed
that U4.4 cells produced a higher percentage than HuH-7 or Vero cells, while HuH-
7 cells produced a higher percentage than Vero cells (P¼0.025 in all three
comparisons). See text for details of statistical analyses.
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